$ADMA 3 SEC Filings

Filed On	Filing
26 Feb 2026	Form 3: Kohler Terry, CFO and Treasurer Holds 58,019 shares of Common Stock
02 Jan 2025	Form 3: Salas Eduardo Rene, Director No securities owned
26 Jul 2024	Form 3: Tade Brad L., CFO and Treasurer Holds 17,033 shares of Common Stock
02 Apr 2024	Form 3: Kestenberg-Messina Kaitlin M., COO and SVP, Compliance Holds 114,275 shares of Common Stock
02 Oct 2023	Form 3: Finger Alison Cecily, Director
18 Oct 2021	Form 3: Kwon Young, Director Holds 100,000 shares of Common Stock
18 Jun 2020	Form 3: Demski Martha J, Director No securities owned
09 Aug 2018	Form 3: Biotest Divestiture Trust, 10% owner Holds 10,109,534 shares of Common Stock
15 Nov 2017	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 3,821,102 shares of Common stock, par value $0.0001 per share
16 Jun 2017	Form 3: Biotest Ag, Director and 1 other Holds 4,295,580 shares of Common Stock
09 Jun 2017	Form 3: Ehmer Bernhard, Director No securities owned
25 Jul 2012	Form 3: Mond James, CSO/CMO Holds 0 shares of No securities are beneficially owned
19 Jul 2012	Form 3: Guiheen Lawrence P., Director Holds 0 shares of No securities are beneficially owned
03 May 2012	Form 3: Lenz Brian, Chief Financial Officer Holds 0 shares of No securities are beneficially owned
16 Feb 2012	Form 3: Aisling Capital Ii Lp, 10% owner and 4 others Holds 2,516,855 shares of Common Stock
15 Feb 2012	Form 3: Burrill Capital Fund IV, L.p., Director and 2 others Holds 0 shares of No securities are beneficially owned
15 Feb 2012	Form 3: Fong Bryant, Director Holds 0 shares of No securities are beneficially owned
15 Feb 2012	Form 3: Richman Eric I, Director Holds 0 shares of No securities are beneficially owned
15 Feb 2012	Form 3: Grossman Adam S, Director Holds 0 shares of No securities are beneficially owned
15 Feb 2012	Form 3: Grossman Jerrold B, Director Holds 0 shares of No securities are beneficially owned

Comments